Patents-Review.com
ClassID:

170812 ⎘

G01N2800/104 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders; Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis Lupus erythematosus [SLE]

Recent Application in this class:
#1
20260133193
2026-05-14

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES

 #2
20260063632
2026-03-05

Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity

 #3
20260023082
2026-01-22

METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #4
20260016489
2026-01-15

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #5
20250346672
2025-11-13

ANTI-FCRN ANTIBODIES

 #6
20250271425
2025-08-28

ALTERNATIVE EXON USAGE IN TRIM21 DETERMINES THE ANTIGENICITY OF RO52/TRIM21 IN SYSTEMIC LUPUS ERYTHEMATOSUS

 #7
20240418715
2024-12-19

URINARY BIOMARKERS FOR ACTIVE LUPUS NEPHRITIS AND METHODS OF USE THEREOF

 #8
20240418714
2024-12-19

COMPOSITIONS AND METHODS FOR FORECASTING RESPONSE TO LUPUS NEPHRITIS (LN)THERAPY

 #9
20240361312
2024-10-31

METHOD FOR EVALUATING SEVERITY OR PROGNOSIS OF MIXED CONNECTIVE TISSUE DISEASE

 #10
20240288441
2024-08-29

METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #11
20240262907
2024-08-08

BIOMARKERS, METHODS, AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE INCLUDING SYSTEMIC LUPUS ERYTHEMATOUS (SLE)

 #12
20240230642
2024-07-11

METHODS AND KITS FOR DIAGNOSING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES

 #13
20240230641
2024-07-11

Methods of Identifying Active Lupus Nephritis Flare

 #14
20240210393
2024-06-27

DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS

 #15
20240041894
2024-02-08

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #16
20240011983
2024-01-11

METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT

 #17
20240003902
2024-01-04

Methods for diagnosing systemic lupus erythematosus

 #18
20230375544
2023-11-23

Methods for Determining a Level of Cell-Bound Complement Activation Product

 #19
20230266315
2023-08-24

Biomarkers for Systemic Lupus Erythematosus Disease, and Intensity and Flare

 #20
20230236188
2023-07-27

METHODS OF DIAGNOSING AND TREATING LUPUS

 #21
20230228768
2023-07-20

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #22
20230194553
2023-06-22

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #23
20230194548
2023-06-22

Methods for diagnosing systemic lupus erythematosus

 #24
20230116530
2023-04-13

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

 #25
20230074480
2023-03-09

BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF

 #26
20230074381
2023-03-09

Anti-FcRn Antibodies

 #27
20230063017
2023-03-02

BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF

 #28
20230045855
2023-02-16

Diagnosis of autoimmune disease

 #29
20230021837
2023-01-26

METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES

 #30
20220344002
2022-10-27

SOLUBLE MEDIATORS FOR PREDICTING SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY EVENTS

 #31
20220299510
2022-09-22

METHODS FOR DIAGNOSING, PROGNOSING AND MONITORING TREATMENT FOR THROMBOSIS IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

 #32
20220283157
2022-09-08

MULTIPLEXED ASSAY KITS FOR EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #33
20220276259
2022-09-01

METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

 #34
20220260564
2022-08-18

Method For Determining Lupus Anticoagulant In A Single Coagulation Reaction

 #35
20220184196
2022-06-16

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES

 #36
20220170945
2022-06-02

METHOD FOR ASSISTING EVALUATION OF RENAL PATHOLOGICAL CONDITIONS, SYSTEM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS AND PROGRAM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS

 #37
20220163524
2022-05-26

METHODS, ARRAYS AND USES THEREOF FOR DIAGNOSING OR DETECTING AN AUTOIMMUNE DISEASE

 #38
20220120730
2022-04-21

METHOD FOR DETECTING SLE

 #39
20220099676
2022-03-31

Disease-associated antigens and methods of use thereof

 #40
20220082567
2022-03-17

Method for detecting a binding of antibodies from a patient sample to double-stranded DNA using Crithidia luciliae cells and fluorescence microscopy

 #41
20220008427
2022-01-13

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

 #42
20220003762
2022-01-06

Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens

 #43
20210405047
2021-12-30

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

 #44
20210389310
2021-12-16

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

 #45
20210349088
2021-11-11

Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity

 #46
20210215692
2021-07-15

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES

 #47
20210139577
2021-05-13

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

 #48
20210055296
2021-02-25

Marker sequences for diagnosing and stratifying SLE patients

 #49
20200393461
2020-12-17

USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS

 #50
20200378966
2020-12-03

MULTIPLEXED ASSAY KITS FOR EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #51
20200360396
2020-11-19

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

 #52
20200341006
2020-10-29

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

 #53
20200292556
2020-09-17

Identification and monitoring of apoptosis inhibitor of macrophage

 #54
20200264172
2020-08-20

Diagnosis of systemic lupus erythematosus using oligonucleotides antigens

 #55
20200225222
2020-07-16

SLE DISEASE MANAGEMENT

 #56
20200209237
2020-07-02

Detection and treatment of autoimmune disorders

 #57
20200209236
2020-07-02

Methods for identifying candidate biomarkers

 #58
20200191784
2020-06-18

BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME

 #59
20200190589
2020-06-18

USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF LUPUS

 #60
20200110087
2020-04-09

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

 #61
20200103418
2020-04-02

DIAGNOSTIC AND THERAPEUTIC METHODS FOR IRAK4-MEDIATED DISORDERS AND CONDITIONS

 #62
20200061176
2020-02-27

Methods and compositions for treating and diagnosing autoimmune diseases

 #63
20200057061
2020-02-20

BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF

 #64
20200049705
2020-02-13

Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare

 #65
20200041504
2020-02-06

BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF

 #66
20200003762
2020-01-02

Diagnostics Platform for Mitochondrial Dysfunctions/Diseases

 #67
20190359566
2019-11-28

Pre-assembled, protected, chemically stable, chemoselective linkers

 #68
20190317090
2019-10-17

COMPOSITIONS AND METHODS FOR FORECASTING RESPONSE TO LUPUS NEPHRITIS (LN)THERAPY

 #69
20190310250
2019-10-10

METHODS FOR THE USE OF GALECTIN 3 BINDING PROTEIN DETECTED IN THE URINE FOR MONITORING THE SEVERITY AND PROGRESSION OF LUPUS NEPHRITIS

 #70
20190302112
2019-10-03

Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupus

 #71
20190300930
2019-10-03

Lytic peptide biosensor and methods of making and using the same

 #72
20190300575
2019-10-03

LYTIC PEPTIDE BIOSENSOR AND METHODS OF MAKING AND USING THE SAME

 #73
20190293643
2019-09-26

Method for Predicting the Response of a Subject with an Autoimmune Disease to a B Cell-Targeting Therapy

 #74
20190262348
2019-08-29

3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

 #75
20190248890
2019-08-15

Anti-FcRn antibodies

 #76
20190233508
2019-08-01

Methods of detecting human IL-21

 #77
20190219573
2019-07-18

Biomarker signatures and uses thereof

 #78
20190195888
2019-06-27

Identification and monitoring of cleaved immunoglobulins by molecular mass

 #79
20190195871
2019-06-27

Diagnosis method for lupus

 #80
20190154690
2019-05-23

METHOD OF TREATING CHRONIC LYMPHATIC LEUKAEMIA AND/OR SYSTEMIC LUPUS ERYTHEMATOSUS

 #81
20190120853
2019-04-25

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

 #82
20190094227
2019-03-28

Disease-associated antigens and methods of use thereof

 #83
20190094219
2019-03-28

Diagnosis of autoimmune diseases

 #84
20190086405
2019-03-21

METHODS OF DIAGNOSING AND TREATING LUPUS

 #85
20190086395
2019-03-21

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

 #86
20190025326
2019-01-24

Methods for diagnosing systemic lupus erythematosus

 #87
20190004044
2019-01-03

Anti-carbamylated protein antibodies and the risk for arthritis

 #88
20190000921
2019-01-03

SEMAPHORIN 3A FOR TREATMENT AND PROGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #89
20180364229
2018-12-20

Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis

 #90
20180348217
2018-12-06

MULTIPLEXED ASSAY KITS FOR EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #91
20180348216
2018-12-06

CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

 #92
20180318387
2018-11-08

METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

 #93
20180277250
2018-09-27

METHODS OF CHARACTERIZING AND/OR PREDICTING RISK ASSOCIATED WITH A BIOLOGICAL SAMPLE USING THERMAL STABILITY PROFILES

 #94
20180267035
2018-09-20

Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1

 #95
20180238873
2018-08-23

Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens

 #96
20180217169
2018-08-02

Method for determining blood specimen

 #97
20180209961
2018-07-26

METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS

 #98
20180120329
2018-05-03

CXCL13 AS AN INDICATOR OF GERMINAL ACTIVITY AND IMMUNE RESPONSE

 #99
20180080931
2018-03-22

Regulatory brain specific ctyoplasmic RNAs (BC RNAs) and methods of use thereof in diagnosis and treatment of neuropsychiatric lupus

 #100
20180073075
2018-03-15

Risk Factors of Cigarette Smoke-Induced Spriometric Phenotypes

 #101
20180057883
2018-03-01

Compositions and Methods for the Diagnosis and Treatment of Lupus Nephritis

 #102
20170343557
2017-11-30

USE OF 5-METHOXYTRYPTOPHAN AS DIAGNOSTIC AGENT OF INFLAMMATORY DISEASES

 #103
20170340702
2017-11-30

Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

 #104
20170322229
2017-11-09

HIGH AFFINITY VITAMIN D3 BINDING PROTEINS

 #105
20170315119
2017-11-02

URINARY BIOMARKERS FOR SLE AND LUPUS NEPHRITIS

 #106
20170299590
2017-10-19

METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS

 #107
20170269075
2017-09-21

BIOMARKERS PREDICTIVE OF LUPUS PROGRESSION AND USES THEREOF

 #108
20170261505
2017-09-14

METHOD AND KIT FOR THE PREDICTIVE PROGNOSIS OF RESPONSIVENESS TO TREATMENTS OF AUTOIMMUNE DISEASES

 #109
20170173029
2017-06-22

3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

 #110
20170074876
2017-03-16

Diagnosis Method for Lupus

 #111
20170074875
2017-03-16

Marker sequences for diagnosing and stratifying SLE patients

 #112
20170067893
2017-03-09

Cell-bound complement activation products as diagnostic biomarkers for pre-lupus

 #113
20170030906
2017-02-02

Predictive biomarkers for detection of organ damage in autoimmune illnesses and other diseases

 #114
20160349256
2016-12-01

Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare

 #115
20160349255
2016-12-01

Fluorometric immunoassay for detection of anti-dsDNA antibodies

 #116
20160349254
2016-12-01

In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis

 #117
20160317626
2016-11-03

Method of reducing accumulation of intracellular tingible body macrophages

 #118
20160299152
2016-10-13

Method for detecting nucleosomes containing histone variants

 #119
20160258950
2016-09-08

Extracellular mitochondrial components for detecting inflammatory reactions and conditions

 #120
20160228505
2016-08-11

Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin

 #121
20160223537
2016-08-04

IDENTIFICATION OF NOVEL BIOMARKERS OF FLARES OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #122
20160131647
2016-05-12

Regulatory brain specific cytoplasmic RNAS (BC RNAs) and methods of use thereof in diagnosis and treatment of neuropsychiatric lupus

 #123
20160131646
2016-05-12

Detection and treatment of autoimmune disorders

 #124
20160129079
2016-05-12

Semaphorin 3A for treatment of systemic lupus erythematosus

 #125
20160125125
2016-05-05

Computer systems for treating diseases

 #126
20160109454
2016-04-21

Disease-associated antigens and methods of use thereof

 #127
20160084833
2016-03-24

DETECTING COMPLEMENT ACTIVATION

 #128
20160069896
2016-03-10

DIAGNOSIS OF AUTOIMMUNE DISEASES USING A SPECIFIC ANTIBODY PROFILE

 #129
20160041164
2016-02-11

Anti-lymphocyte autoantibodies as diagnostic biomarkers

 #130
20160011209
2016-01-14

Application of N-terminomics to NETosis in inflammation

 #131
20150376679
2015-12-31

Methods for analyzing glycan-derived monosaccharides

 #132
20150369824
2015-12-24

Methods for treating and diagnosing systemic lupus erythematosus

 #133
20150118240
2015-04-30

Anti-FcRn antibodies

 #134
20150098940
2015-04-09

Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare

 #135
20150011419
2015-01-08

SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS

 #136
20140363829
2014-12-11

Method for increasing specificity of diagnostic tests for autoimmune diseases

 #137
20140363450
2014-12-11

Oxidized cardiolipin as a pro-inflammatory factor

 #138
20140342939
2014-11-20

DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #139
20140234863
2014-08-21

Immunoassay methods

 #140
20140221245
2014-08-07

Immunoassay methods

 #141
20140220014
2014-08-07

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

 #142
20140162297
2014-06-12

Anti-carbamylated protein antibodies and the risk for arthritis

 #143
20140162282
2014-06-12

Methods for determining drug efficacy using cereblon-associated proteins

 #144
20140127726
2014-05-08

Method of measuring blood coagulation time to detect lupus anticoagulants

 #145
20140127725
2014-05-08

Method for detecting lupus anticoagulants

 #146
20140011895
2014-01-09

Biomarkers for systemic lupus erythematosus

 #147
20130309698
2013-11-21

Methods for diagnosing systemic lupus erythematosus

 #148
20130218475
2013-08-22

Computer systems for treating diseases

 #149
20130151165
2013-06-13

Computer systems for treating diseases

 #150
20130035254
2013-02-07

DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

 #151
20130022985
2013-01-24

EXAMINATION METHOD TO DETERMINE CONTRACTION OR ACTIVITY OF DISEASES RELATED IMMUNE SYSTEM OR JOINT SYSTEM

 #152
20120315266
2012-12-13

Detecting complement activation

 #153
20120308578
2012-12-06

SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES

 #154
20120270741
2012-10-25

Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics

 #155
20120269799
2012-10-25

DIAGNOSTIC AND TREATMENT METHODS USING A LIGAND LIBRARY

 #156
20120258883
2012-10-11

METHOD OF USING CYTOKINE ASSAYS TO DIAGNOSE, TREAT, AND EVALUATE INFLAMMATORY AND AUTOIMMUNE DISEASES

 #157
20120220640
2012-08-30

Methods of treating diseases

 #158
20120219555
2012-08-30

Methods of treating lupus

 #159
20120213768
2012-08-23

Diagnostic and Therapeutic Uses for B Cell Maturation Antigen

 #160
20120208743
2012-08-16

Use of gelsolin to diagnose and treat inflammatory diseases

 #161
20120190581
2012-07-26

Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases

 #162
20120130350
2012-05-24

DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS

 #163
20120122241
2012-05-17

IDENTIFICATION AND MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS

 #164
20120121571
2012-05-17

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

 #165
20120052585
2012-03-01

Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant

 #166
20120052066
2012-03-01

MARKERS AND METHODS FOR ASSESSING AND TREATING LUPUS PATIENTS SUSCEPTIBLE TO PHOTOPROVOCATION

 #167
20120015992
2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

 #168
20120004311
2012-01-05

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

 #169
20120004130
2012-01-05

AUTOIMMUNE DISEASE BIOMARKERS

 #170
20120003228
2012-01-05

METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK

 #171
20110311999
2011-12-22

Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus

 #172
20110300529
2011-12-08

DETECTION OF IFI16 IN BODY FLUIDS

 #173
20110257492
2011-10-20

METHOD FOR DETERMINING THE STATE OF A SKIN DISORDER USING NEAR INFRARED (NIR) SPECTROSCOPY

 #174
20110256121
2011-10-20

METHODS AND KITS FOR DIAGNOSING OR MONITORING AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES

 #175
20110250218
2011-10-13

Disease-Associated Antigens and Methods of Use Thereof

 #176
20110250208
2011-10-13

Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor

 #177
20110237688
2011-09-29

Methods and compositions related to acetylocholine receptor conjugates

 #178
20110236912
2011-09-29

SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS

 #179
20110207613
2011-08-25

BIOMARKERS FOR LUPUS

 #180
20110201017
2011-08-18

LUPUS ANTICOAGULENT TESTING

 #181
20110195073
2011-08-11

COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE

 #182
20110171207
2011-07-14

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES

 #183
20110136140
2011-06-09

DIAGNOSIS OF SYSTEMIC DISEASES

 #184
20110039354
2011-02-17

Method of Characterizing and Quantifying Calcifying Nanoparticles

 #185
20110028409
2011-02-03

DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES

 #186
20110027822
2011-02-03

SYSTEMIC LUPUS ERYTHEMATOSUS

 #187
20110014608
2011-01-20

Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases

 #188
20110014215
2011-01-20

Granulysin and uses thereof

 #189
20110008789
2011-01-13

METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS

 #190
20100322928
2010-12-23

METHODS OF DIAGNOSING, MONITORING TREATMENT AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

 #191
20100297127
2010-11-25

USE OF IL-27 ANTAGONISTS TO TREAT LUPUS

 #192
20100267781
2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

 #193
20100233752
2010-09-16

METHOD FOR DIAGNOSIS AND MONITORING OF DISEASE ACTIVITY AND RESPONSE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND OTHER AUTOIMMUNE DISEASES

 #194
20100227807
2010-09-09

Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis

 #195
20100227415
2010-09-09

METHOD AND MEANS FOR PREDICTION OF SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY

 #196
20100178652
2010-07-15

Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease

 #197
20100151487
2010-06-17

Hepcidins as biomarkers for impending lupus nephritis flare

 #198
20100144055
2010-06-10

Assays For Clinical Assessments of Disease-Associated Autoantibodies

 #199
20100105085
2010-04-29

METHOD OF DIAGNOSING AND STRATIFYING ANTI-PHOSPHOLIPID SYNDROME

 #200
20100092977
2010-04-15

IRF-5 haplotypes in systemic lupus erythematosus

 #201
20100075348
2010-03-25

Method for diagnosis of a disease involving an anti-endothelin-receptor antibody

 #202
20100029007
2010-02-04

Biomarker in Inflammatory Diseases

 #203
20090325196
2009-12-31

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS

 #204
20090325167
2009-12-31

METHOD OF USING CYTOKINE ASSAY TO DIAGNOSE, TREAT, AND EVALUATE INFLAMMATORY AND AUTOIMMUNE DISEASES

 #205
20090324575
2009-12-31

Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

 #206
20090299948
2009-12-03

Identification and monitoring of systemic lupus erythematosus

 #207
20090288960
2009-11-26

Rapid Detection of Anti-Chromatin Autoantibodies in Human Serum using a Portable Electrochemical Biosensor

 #208
20090202474
2009-08-13

EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES

 #209
20090136945
2009-05-28

COMPOSITIONS AND METHODS FOR ASSESSING DISORDERS

 #210
20090130683
2009-05-21

Predicting and diagnosing patients with autoimmune disease

 #211
20090110667
2009-04-30

Detection and treatment of autoimmune disorders

 #212
20080299110
2008-12-04

Method for diagnosing and treating acute joint injury

 #213
20080254482
2008-10-16

AUTOIMMUNE DISEASE BIOMARKERS

 #214
20080227689
2008-09-18

Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1

 #215
20080206235
2008-08-28

COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE

 #216
20080171344
2008-07-17

Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase

 #217
20080160036
2008-07-03

Compositions and methods for treating inflammation and auto-immune diseases

 #218
20080057066
2008-03-06

METHODS AND COMPOSITIONS FOR TARGETING RELT

 #219
20080050382
2008-02-28

Granulysin and uses thereof

 #220
20080045700
2008-02-21

Canine CD20 Compositions

 #221
20080026386
2008-01-31

IRF-5 HAPLOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS

 #222
20070264662
2007-11-15

Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3

 #223
20070248605
2007-10-25

Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention

 #224
20070178536
2007-08-02

Identification and monitoring of systemic lupus erythematosus

 #225
20070141627
2007-06-21

Systemic Lupus Erythematosus

 #226
20070087390
2007-04-19

OPIATE, CANNABINOID, AND ESTROGEN RECEPTORS

 #227
20070031820
2007-02-08

Specific bacterial inclusions in bone marrow cells indicate systematic lupus erthematosus, and treatment for lupus

 #228
20070026467
2007-02-01

Lupus anticoagulant testing

 #229
20070020673
2007-01-25

Model of autoimmune disease and methods for identifying agents against autoimmune disease

 #230
20070003543
2007-01-04

Low dose histone peptide treatment for autoimmune disorders

 #231
20060240477
2006-10-26

Analytical method and kit thereof

 #232
20060216716
2006-09-28

Immunologic activity measures for t helper on-associated conditions

 #233
20060177814
2006-08-10

Systemic lupus erythematosus

 #234
20060127391
2006-06-15

Method of treating multiple sclerosis with anti-K6 antibody

 #235
20060094056
2006-05-04

Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases

 #236
20060051778
2006-03-09

Diagnosis of systemic lupus erythematosus

 #237
20060030524
2006-02-09

Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens

 #238
20050282234
2005-12-22

Real time method of detecting acute inflammatory conditions

 #239
20050271662
2005-12-08

Canine CD20 compositions

 #240
20050233322
2005-10-20

Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (DLE)

 #241
20050214852
2005-09-29

Peptides for detecting anti-double stranded DNA antibody and uses thereof

 #242
20050142616
2005-06-30

Diagnostic test for neuropsychiatric systemic lupus erythematosus

 #243
20050037441
2005-02-17

Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma